Citigroup’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-267,800
Closed -$26.6M 8000
2019
Q3
$26.6M Sell
267,800
-82,400
-24% -$7.83M 0.02% 768
2019
Q2
$32.4M Sell
350,200
-1,439,600
-80% -$137M 0.03% 645
2019
Q1
$169M Buy
1,789,800
+1,284,100
+254% +$112M 0.16% 105
2018
Q4
$32.4M Sell
505,700
-56,900
-10% -$4.2M 0.03% 579
2018
Q3
$50.3M Sell
562,600
-222,600
-28% -$19.7M 0.04% 386
2018
Q2
$62.4M Buy
785,200
+85,000
+12% +$7.06M 0.06% 290
2018
Q1
$62.5M Sell
700,200
-13,200
-2% -$1.27M 0.05% 324
2017
Q4
$74.5M Buy
713,400
+72,700
+11% +$8.2M 0.06% 297
2017
Q3
$93.4M Buy
640,700
+31,900
+5% +$4.35M 0.08% 214
2017
Q2
$79.1M Sell
608,800
-34,500
-5% -$4.23M 0.07% 218
2017
Q1
$80M Buy
643,300
+195,900
+44% +$23.4M 0.07% 234
2016
Q4
$51.8M Buy
447,400
+10,900
+2% +$1.21M 0.05% 377
2016
Q3
$45.6M Buy
436,500
+107,800
+33% +$11.7M 0.04% 366
2016
Q2
$32.4M Sell
328,700
-20,700
-6% -$2.14M 0.03% 451
2016
Q1
$35M Sell
349,400
-182,600
-34% -$18.8M 0.04% 401
2015
Q4
$63.7M Buy
532,000
+14,100
+3% +$1.63M 0.06% 285
2015
Q3
$56M Sell
517,900
-8,600
-2% -$1.07M 0.05% 317
2015
Q2
$60.9M Sell
526,500
-21,400
-4% -$2.45M 0.05% 329
2015
Q1
$63.2M Sell
547,900
-241,600
-31% -$28.9M 0.06% 292
2014
Q4
$88.3M Buy
789,500
+94,600
+14% +$9.98M 0.08% 241
2014
Q3
$65.9M Buy
694,900
+104,000
+18% +$9.39M 0.06% 311
2014
Q2
$50.7M Buy
590,900
+17,100
+3% +$1.3M 0.05% 354
2014
Q1
$40.1M Sell
573,800
-282,200
-33% -$22.3M 0.04% 401
2013
Q4
$72.3M Buy
856,000
+204,200
+31% +$16.2M 0.07% 276
2013
Q3
$50.2M Buy
651,800
+153,000
+31% +$10.7M 0.05% 346
2013
Q2
$29.2M Buy
+498,800
New +$30M 0.03% 506

Other funds holding CELG

Citigroup's CELG Position: Q4 2019 in Review

Citigroup sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 7,545,707 shares — an estimated $749M sold.

Citigroup first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $749M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Citigroup reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Citigroup sold 7,545,707 Celgene Corp shares in Q4 2019, an estimated $749M.
  • Citigroup first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Citigroup's Celgene Corp position peaked at $749M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Citigroup's 13F filing for Q4 2019, filed 12 Feb 2020.